Eli Lilly and Company (LLY) vs Constellation Brands, Inc. (STZ)
A side-by-side comparison of Eli Lilly and Company and Constellation Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: LLY is classified in Healthcare; STZ is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
LLY
Eli Lilly and Company
$1,222.61HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
STZ
Constellation Brands, Inc.
$132.02Consumer DefensiveDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — LLY vs STZ
growth of $100 · dividends reinvested · last 30yLLY +8631.2%STZ +4597.4%LLY compounded faster
LLY STZ
LLY vs STZ: by the numbers
- •LLY is the larger company ($1.15T vs $22.55B market cap).
- •STZ trades at the lower trailing earnings multiple (12.38 vs 42.54 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 20.14% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 0.86% CAGR).
- •STZ pays the higher dividend yield (3.15% vs 0.54%).
Metrics side by side
Valuation
| Metric | LLY | STZ |
|---|---|---|
| P/E ratio | 42.54 | 12.38 |
| Forward P/E | 34.10 | 11.14 |
| P/S ratio | 14.85 | 2.47 |
| P/B ratio | 34.39 | 2.71 |
| PEG ratio | 0.49 | N/A |
| EV / EBITDA | 31.98 | 9.87 |
| FCF yield | 1.27% | 8.20% |
Profitability
| Metric | LLY | STZ |
|---|---|---|
| Gross margin | 83.51% | 52.62% |
| Operating margin | 45.87% | 32.14% |
| Net margin | 34.98% | 20.14% |
| ROE | 81.01% | 22.10% |
| ROIC | 30.20% | 10.48% |
Dividends
| Metric | LLY | STZ |
|---|---|---|
| Dividend yield | 0.54% | 3.15% |
| Payout ratio | 28.09% | 42.52% |
Growth (annualized)
| Metric | LLY | STZ |
|---|---|---|
| Revenue CAGR (5Y) | 23.17% | 0.86% |
| EPS CAGR (5Y) | 28.88% | -1.59% |
| FCF CAGR (5Y) | 19.54% | -1.73% |
| Total return CAGR (5Y) | 38.81% | -8.34% |
Frequently asked
- Which has the lower trailing P/E, LLY or STZ?
- STZ has the lower trailing P/E: LLY trades at 42.54 and STZ at 12.38. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, LLY or STZ?
- Over the past five years, LLY grew revenue faster — LLY at a 23.17% CAGR versus STZ at 0.86%.
- Does LLY or STZ pay a bigger dividend?
- LLY yields 0.54% and STZ yields 3.15% based on trailing dividends and the latest price.
- Is LLY or STZ more profitable?
- LLY runs the higher net margin — LLY at 34.98% versus STZ at 20.14%.
- How have LLY and STZ total returns compared?
- Over the past 10 years, LLY delivered 32.66% and STZ delivered -0.43% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eli Lilly and P/E ratioConstellation Brands P/E ratioEli Lilly and dividend yieldConstellation Brands dividend yieldEli Lilly and ROEConstellation Brands ROEEli Lilly and operating marginConstellation Brands operating marginEli Lilly and revenue growthConstellation Brands revenue growthEli Lilly and free cash flowConstellation Brands free cash flow
Eli Lilly and & Constellation Brands appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.